LAUREN MEYERSON: Open Payments
NPI 1124805536 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,666 in 56 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $1,081 · 2025 $1,666
Food & beverage: $1,666
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 20 | $595 |
| GlaxoSmithKline, LLC. | 12 | $515 |
| AstraZeneca Pharmaceuticals LP | 14 | $307 |
| Eisai Inc. | 7 | $151 |
| ABBVIE INC. | 1 | $35 |
| Caris MPI, Inc. | 1 | $35 |
| Tempus AI, Inc | 1 | $28 |
Products named: JEMPERLI, LYNPARZA, KEYTRUDA, Lenvima, ELAHERE, MI CANCER SEEK, XT CDX.
Industry payments across CA — which companies pay providers there.
